TMO

TMO Operating Expenses

$10.69BTTM · USD

Period ending:

TMO FY Operating ExpensesUSD
TMO FY Operating Expenses1985-12-31: $86.50M1986-12-31: $100.00M1987-12-31: $127.20M1988-12-31: $155.70M1989-12-31: $177.10M1990-12-31: $229.40M1991-12-31: $257.00M1992-12-31: $300.90M1993-12-31: $413.00M1994-12-31: $539.20M1995-12-31: $835.40M1996-12-31: $1.11B1997-12-31: $1.31B1998-12-31: $1.47B1999-12-31: $957.70M2000-12-31: $823.68M2001-12-31: $791.72M2002-12-31: $719.78M2003-12-31: $714.53M2004-12-31: $761.14M2005-12-31: $943.68M2006-12-31: $1.32B2007-12-31: $2.83B2008-12-31: $2.98B2009-12-31: $2.95B2010-12-31: $3.01B2011-12-31: $3.39B2012-12-31: $3.79B2013-12-31: $3.83B2014-12-31: $5.54B2015-12-31: $5.34B2016-12-31: $5.72B2017-12-31: $6.41B2018-12-31: $7.12B2019-12-31: $7.09B2020-12-31: $8.13B2021-12-31: $9.32B2022-12-31: $10.49B2023-12-31: $9.75B2024-12-31: $10.07B2025-12-31: $10.13B$10.49B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TMO operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Thermo Fisher Scientific Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
10,129,000,000
10,066,000,000
9,748,000,000
10,486,000,000
9,316,000,000
8,130,000,000
7,085,000,000
7,116,000,000
6,412,000,000
5,723,000,000
5,343,500,000
5,537,100,000
3,827,000,000
3,785,000,000
3,385,200,000
3,010,200,000
2,952,400,000
2,976,100,000
2,828,300,000
1,321,651,000
943,683,000
761,138,000
714,532,000
719,777,000
791,718,000
823,676,000
957,700,000
1,467,200,000
1,313,700,000
1,105,900,000
835,400,000
539,200,000
413,000,000
300,900,000
257,000,000
229,400,000
177,100,000
155,700,000
127,200,000
100,000,000
86,500,000

Compare operating expenses

All TMO financial metrics · TMO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.